Viewing Study NCT01557959

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:28 PM
Ignite Modification Date: 2026-02-03 @ 7:46 AM
Study NCT ID: NCT01557959
Status: COMPLETED
Last Update Posted: 2018-06-29
First Post: 2012-02-14
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Sponsor: Wake Forest University Health Sciences
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adenocarcinoma of the Lung View
None Adenosquamous Cell Lung Cancer View
None Bronchoalveolar Cell Lung Cancer View
None Large Cell Lung Cancer View
None Non-small Cell Lung Cancer View
None Recurrent Non-small Cell Lung Cancer View
None Squamous Cell Lung Cancer View
None Stage IIIB Non-small Cell Lung Cancer View
None Stage IV Non-small Cell Lung Cancer View
Keywords: